Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Methotrexate Well Tolerated, Effective for Psoriasis in Chinese
THURSDAY, Jan. 31, 2019 (HealthDay News) -- Methotrexate is well tolerated and effective for psoriasis in a Chinese population and is more effective for those without psoriatic arthritis, according to a study published online Jan. 30 in JAMA Dermatology.
Evidence Lacking for Benefit of Surgery for Vertebral Fractures
MONDAY, Jan. 28, 2019 (HealthDay News) -- Surgical procedures do not appear to provide significant benefit for patients with vertebral fractures (VF), according to a second American Society for Bone and Mineral Research Task Force report published in the January issue of the Journal of Bone and Mineral Research.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) -- In a report published in the January issue of Value in Health, an ISPOR--The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Heberden's Nodes in Fingers Tied to Knee Osteoarthritis
TUESDAY, Jan. 22, 2019 (HealthDay News) -- The presence of Heberden's nodes (HNs) in finger joints may also indicate structural damage associated with knee osteoarthritis, according to a study published online Jan. 9 in Arthritis & Rheumatology.
Radiographic Knee Osteoarthritis Tied to Increased Risk for Death
FRIDAY, Jan. 18, 2019 (HealthDay News) -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD), diabetes, and renal diseases, but self-reported OA is not, according to a study published in the December issue of the International Journal of Epidemiology.
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) -- Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
Hemochromatosis Mutation Linked to Other Morbidity
THURSDAY, Jan. 17, 2019 (HealthDay News) -- HFE p.C282Y homozygosity, the most common gene mutation causing hereditary hemochromatosis (type 1), is associated with other morbidity in men and women, according to a study published online Jan. 16 in The BMJ.
Prevalence of Knee OA Lower With Menopausal Hormone Therapy
THURSDAY, Jan. 17, 2019 (HealthDay News) -- For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause.
Adoption of Advanced Health IT Capabilities Inconsistent
WEDNESDAY, Jan. 16, 2019 (HealthDay News) -- Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
Study Explores Influence of Genetics, Environment in Disease
TUESDAY, Jan. 15, 2019 (HealthDay News) -- The influence of heritability and environmental factors has been identified for a large number of phenotypes, according to a study published online Jan. 14 in Nature Genetics.
American College of Physicians Releases 7th Edition of Ethics Manual
TUESDAY, Jan. 15, 2019 (HealthDay News) -- Ethical principles are discussed in an updated Ethics Manual, issued by the American College of Physicians (ACP) and published as a supplement to the Jan. 15 issue of the Annals of Internal Medicine.
One in Five Back Pain Patients Experience Persistent Pain
MONDAY, Jan. 14, 2019 (HealthDay News) -- Eighteen percent of patients with back pain experience a persistent trajectory, according to a study published online Jan. 14 in Arthritis Care & Research.
Prices Still Explain High U.S. Health Care Spending
FRIDAY, Jan. 11, 2019 (HealthDay News) -- The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs.
Private Equity Acquisition of Physician Practices Discussed
THURSDAY, Jan. 10, 2019 (HealthDay News) -- The phenomenon of private equity acquisition of physician practices is discussed in an Ideas and Opinions piece published online Jan. 8 in the Annals of Internal Medicine.
Many Female Health Care Workers Live in Poverty
WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- Many U.S. female health care workers, particularly women of color, live in poverty and lack health insurance, according to a study published online Dec. 20 in the American Journal of Public Health.
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
WEDNESDAY, Jan. 9, 2019 (HealthDay News) -- The costs of oral and injectable brand-name drugs increased from 2008 to 2016, with most of the increase due to existing drugs, while new drugs accounted for cost increases in specialty and generic drugs, according to a study published in the January issue of Health Affairs.
Medical Marketing Has Increased in Past 20 Years
TUESDAY, Jan. 8, 2019 (HealthDay News) -- From 1997 through 2016, there was an increase in medical marketing, especially direct-to-consumer (DTC) advertising, according to research published in the Jan. 1/8 issue of the Journal of the American Medical Association.
ACA Coverage Gains Could Erode Without Individual Mandate
TUESDAY, Jan. 8, 2019 (HealthDay News) -- Eliminating the Affordable Care Act's individual mandate penalty is unlikely to destabilize the individual market in California but could roll back coverage gains, according to a study published in the January issue of Health Affairs.
Patients With Sleep Apnea Have Increased Gout Risk
THURSDAY, Jan. 3, 2019 (HealthDay News) -- Patients with obstructive sleep apnea (OSA) are at higher risk for developing gout than patients without OSA for more than a year after diagnosis, according to a study published in the January issue of Arthritis & Rheumatology.